Glaucoma Trial, Recruiting NCT07303257 Sponsor: Hospices Civils de Lyon Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT07303257
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who have been recommended for glaucoma surgery
  • People whose planned surgery is one of three specific procedures: Preserflo™ MicroShunt with mitomycin C, trabeculectomy with mitomycin C, or non-penetrating deep sclerectomy with mitomycin C
  • People with glaucoma affecting one or both eyes, including open-angle or angle-closure glaucoma at any stage (early, moderate, or advanced)
  • People with pseudoexfoliative glaucoma or pigmentary glaucoma (two specific types caused by material or pigment buildup in the eye)
  • People with certain secondary forms of glaucoma, including glaucoma caused by eye inflammation (uveitic), long-term steroid use (steroid-induced), or eye injury (traumatic)
  • People who have given written consent to take part before the study begins

Who may not be able to join:

  • People with congenital glaucoma (glaucoma present from birth)
  • People with difficult-to-treat glaucoma who have already had multiple previous eye surgeries
  • People who have had any eye surgery within the 6 months before joining the study
  • People with serious eye conditions affecting vision, such as age-related macular degeneration, severe diabetic retinopathy, or retinal degeneration
  • People who may have difficulty attending all follow-up appointments, including those with plans to travel or be away for extended periods during the study
  • People who are unable to read, unable to communicate in French, or who have a cognitive condition that would prevent them from fully understanding the study
  • People who already have a significantly reduced quality of life due to a progressive physical illness or a neuropsychiatric condition
  • People who are under a legal guardianship or curatorship arrangement (a court-appointed arrangement where another person manages their affairs)
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 426109431

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
23 February 2026
Est. completion
1 August 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Quality of life score from the NEI-VFQ-25 (National Eye Institute Visual Function Questionnaire-25).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov